Relay Therapeutics CFO sells 17,717 shares in Form 4 filing
Relay Therapeutics Chief Financial Officer Thomas Catinazzo reported selling 17,717 shares at $18.59 each in a Form 4 filing. The filing said the sale was made under a 10b5-1 plan.
Relay Therapeutics Chief Financial Officer Thomas Catinazzo reported selling 17,717 shares at $18.59 each in a Form 4 filing. The filing said the sale was made under a 10b5-1 plan.